脑通胶囊对VD大鼠海马NMDA受体 mRNA表达及锥体细胞的影响

张树森; 况时祥; 肖雁; 官志忠

您当前的位置：

首页 >

文章列表页 >

脑通胶囊对VD大鼠海马NMDA受体 mRNA表达及锥体细胞的影响

更新时间：2024-01-04

- 脑通胶囊对VD大鼠海马NMDA受体 mRNA表达及锥体细胞的影响
- Effect of Naotong Capsule on the NMDA Receptors and Pyramidal Cells in Hippocampus of Vascular Dementia Model Rats
- 中国实验方剂学杂志 2012年18卷第10期页码：230-235
- 作者机构：
- 作者简介：
- 基金信息：
  
  贵州省科技攻关计划项目(黔科合SY字[2008]3048号);教育部春晖计划项目(Z2005-2-5027);贵州省中医药管理局项目(黔中医药2007020)
- DOI：
  中图分类号：
- 纸质出版日期：2012
- 稿件说明：
移动端阅览
张树森, 况时祥, 肖雁, 等. 脑通胶囊对VD大鼠海马NMDA受体 mRNA表达及锥体细胞的影响[J]. 中国实验方剂学杂志, 2012,18(10):230-235.

ZHANG Shu-sen, KUANG Shi-xiang, XIAO Yan, et al. Effect of Naotong Capsule on the NMDA Receptors and Pyramidal Cells in Hippocampus of Vascular Dementia Model Rats[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(10): 230-235.
张树森, 况时祥, 肖雁, 等. 脑通胶囊对VD大鼠海马NMDA受体 mRNA表达及锥体细胞的影响[J]. 中国实验方剂学杂志, 2012,18(10):230-235. DOI：

ZHANG Shu-sen, KUANG Shi-xiang, XIAO Yan, et al. Effect of Naotong Capsule on the NMDA Receptors and Pyramidal Cells in Hippocampus of Vascular Dementia Model Rats[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(10): 230-235. DOI：

摘要

目的: 观察脑通胶囊对血管性痴呆(VD)大鼠学习记忆、海马N-甲基-D-天冬氨酸(NMDA)受体及锥体细胞的影响。方法: 随机抽取大鼠19只作为假手术组

其余采用改良的四血管法(4-VO)制备VD模型并随机分为模型组、尼莫地平组(12 mg·kg-1·d-1)、脑通胶囊高剂量组(1 200 mg·kg-1·d-1)、脑通胶囊中剂量组(600 mg·kg-1·d-1)、脑通胶囊低剂量组(300 mg·kg-1·d-1)。Morris水迷宫测定各组大鼠学习记忆能力

实时荧光定量PCR检测NMDA受体1亚基和2B亚基mRNA的表达情况

光镜观察海马CA1区锥体细胞形态及数量变化。结果: 与模型组比较

脑通胶囊高、中剂量组逃避潜伏期缩短(P＜0.01)

穿越原平台次数增加(P＜0.01

P＜0.05)

NMDA受体1亚基 mRNA表达降低(P＜0.01)

2B亚基 mRNA表达升高(P＜0.01

P＜0.05);海马CA1区锥体细胞形态未见明显病变现象

锥体细胞数量增多

锥体细胞丢失比率减少。与尼莫地平组比较

脑通胶囊高、中剂量组穿越原平台次数增加(P＜0.01)

NMDA受体1亚基mRNA相对表达量降低(P＜0.01)

高剂量组NMDA受体2B亚基mRNA相对表达量增加(P＜0.05)

CA1区锥体细胞增多(P＜0.01)。结论: 脑通胶囊可降低海马NMDA受体1亚基 mRNA的表达

提高2B亚基 mRNA的表达

减轻海马CA1区锥体细胞损伤

减少锥体细胞丢失比率

从而改善VD大鼠学习记忆能力

这可能是其治疗VD的作用机制之一。

Abstract

Objective: To observe the effects of Naotong Capsule on N-methyl-D-aspartic acid receptor(NMDA) receptors and pyramidal cells in hippocampus of vascular dementia (VD) model rats. Method: Nineteen rats were taken at random into sham group

the rest were VD models established by modified Pulsinelli 4 vascular occlusions method (4-VO) and were randomly divided into model group

nimodipine group(12 mg·kg-1·d-1)

Naotong Capsule large-dose group(1 200 mg·kg-1·d-1)

Naotong Capsule middle-dose group(600 mg·kg-1·d -1)

and Naotong Capsule low-dose group(300 mg·kg-1·d-1). Morris water maze was used to test learning and memory abilities of rats. The mRNA expression level of NMDA receptors (subunit 1 and 2B) were determined by the Real-time Quantitative PCR. And the morphology and number of neurons in CA1 region of the hippocampus were observed by light microscope. Result: Compare to the model group

the escape time was shortened(P＜0.01)

times of spanning the previous platform increased (P＜0.01

P＜0.05)

the mRNA expression level of subunit 1 decreased(P＜0.01) and the mRNA expression level of subunit 2B increased(P＜0.01

P＜0.05)

pyramidal cells showed no obvious pathogenesis and more pyramidal cells with less pyramidal cells loss rate were found in Naotong Capsule large-dose and middle-dose treatment group. Compare to the Nimodipine group

times of spanning the previous platform increased(P＜0.01)

the mRNA expression level of subunit 1 decreased(P＜0.01) in Naotong Capsule large-dose and middle-dose treatment group

and the mRNA expression level of subunit 2B increased(P＜0.05)

the number of neurons in CA1 region of the hippocampus increased(P＜0.01) in Naotong Capsule large-dose treatment group. Conclusion: Naotong Capsule can improve learning and memory abilities of VD rats by decreasing the mRNA expression level of subunit 1

increasing the mRNA expression level of subunit 2B of NMDA receptor and by decreasing pyramidal cells injury and loss rate in CA1 region of the hippocampus

which may be one of the therapeutic mechanisms of VD.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

黄连解毒汤调控FBXL5/IRP2改善VaD小鼠脑铁代谢紊乱、髓鞘损伤及激越攻击行为

基于HIF-1α/BNIP3信号通路调控线粒体自噬探讨通脉开窍丸治疗血管性痴呆大鼠的机制

基于MCT1调控的髓鞘轴突能量代谢探究加减薯蓣丸改善血管性痴呆伴抑郁小鼠抑郁行为和髓鞘再生

天智颗粒治疗轻中度血管性痴呆的安全性评价

基于中西医结合的血管性痴呆发病机制及治疗的研究进展